P-128 is under clinical development by GangaGen Biotechnologies and currently in Phase II for Staphylococcus aureus Infections.

Pune: Doctors have reported a steady increase in infections resistant to antibiotics among children in the city, indicating that humans without the us.

Methicillin-resistant Staphylococcus aureus; MSSA: Methicillin-susceptible Staphylococcus aureus. Staphylococcus aureus is a leading cause of nosocomial and community acquired infections.

The microbe poses a significant threat to public health, made worse by the spread of methicillin-resistant Staphylococcus aureus bacteria (MRSA) in recent years. According to The Lancet ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Without treatment, the infection can enter ... which is the incubation period for the infection. Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph bacteria highly resistant ...

In April 2024, the U.S. Food and Drug Administration (FDA) approved Zevtera for three specific treatment indications, and it is the only FDA-approved methicillin-resistant Staphylococcus aureus ...

Purpose. The pharmacology, antimicrobial activity, pharmacokinetics, pharmacodynamics, clinical efficacy, safety, and place in therapy of ceftobiprole are reviewed. Conclusion. Ceftobiprole is a ...

Hospitals in New Jersey rank fifth best in the nation for protecting patients from injuries and medical errors and preventing ...

Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

Most diabetic wound care products are passive dressings, only providing a protective barrier against the external environment ...